ARCHIVES

XGEVA not Inferior to Zometa In 1,776-Patient Phase III Study

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: Levin Leaves UCSF for M.D. Anderson; Copeland Moves to Ohio State; OC’s Alice Hamm Retires

July 1, 1988

In Brief: President Proposes $1,994 Billion For NCI;

February 10, 1995

In Brief: NIH Study Finds Intramural Program Tenures Few Minorities, Calls For Improvements

March 11, 1994

The Cancer Letter Offers FAX Delivery

January 7, 1994

Review Guidelines For Comprehensive Centers Drafted, NCAB To Consider at December Meeting

November 24, 1989

Intramural Review System Described

September 10, 1982